Financials
- Market Capitalization 18.77 M
- Employee 8
- Founded 2021
- CEO N/A
- Website www.allarity.com
- Headquarter Delaware, United States
- FIGI BBG012NXCZP8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.38
ratio cours/chiffre d'affaires
48.53
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4637 | ATOS Atossa Therapeutics, Inc. - Common Stock | 2.24 USD | -6.67% | -10.04% | -10.76% | +138.30% | 19.29 M USD | ||
| 4638 | LPCN Lipocine Inc. - Common Stock | 2.31 USD | -1.70% | -3.35% | +2.21% | -20.34% | 19.04 M USD | ||
| 4643 | JSPR Jasper Therapeutics, Inc. - Class A Common Stock | 0.71 USD | +16.39% | +47.92% | +57.78% | -79.71% | 19.88 M USD | ||
| 4646 | NCEL NewcelX Ltd. - Ordinary Shares | 3.98 USD | -0.50% | +0.51% | +20.61% | -21.65% | 19.09 M USD |